Canopy Growth Stock Just Hit 52-Week Lows: Bargain or Beware?

Canopy Growth (TSX:WEED) stock announced earnings last week which included updated numbers related to BioSteel.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth (TSX:WEED) fell to 52-week lows yet again this week, as Canopy Growth stock announced its most recent earnings. Shares have plunged 86% in the last year with no end in sight.

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

BioSteel mess

Canopy Growth stock announced further staff cuts in its latest earnings report, with specific attention placed on its BioSteel business. The company announced it would laying off several members of the BioSteel leadership team, and are currently in review of BioSteel to see if there are “legal remedies” open to the cannabis producer.

The remarks were made after Canopy Growth stock announced it would refile three of its past quarterly financial statements because of “misstatements” linked to BioSteel. Sales from the brand “should no longer be relied upon” the company said after going over its financial results for the financial year.

New details came out during the quarter and full-year results, providing investors with more reasons to apparently drop the stock.

More losses

Canopy Growth stock announced net loss in the fourth quarter came to $648 million, a $59 million increase on losses from the year before. Much of the loss, management stated, came from asset impairment and restructuring costs totaling around $164 million.

As for BioSteel, the corrected numbers saw a decrease of $10 million in net revenue for the 2022 year. The correction in numbers led to a $10 million decrease in net revenue for the year, and $14 million decrease in net revenue for the last nine months ending on Dec. 31, 2022.

Its other revenue sources from cannabis also came in lower. Net revenue for Canopy Growth stock was down 14% to $88 million, with its adjusted loss reaching $96 million. This was an improvement of $36 million from its negative adjusted earnings before interest, taxes, depreciation, and amortization last year.

Where Canopy Growth stock is headed next

It wasn’t all bad news, with Canopy Growth stock still seeing 101% increase in revenue for BioSteel. Plus, cost savings came in from the departure of 800 workers, or about 35% of its workforce back in February.

Still, cost savings from cuts isn’t what investors want to see. It also led to analysts cutting their price targets for the stock, with some pushing down its target price to under $1.

It’s certainly a long way down from the all-time highs reached by the cannabis stock before legalization in Canada. And, of course, investors want to know if it can turn things around.

As for now, that doesn’t look likely in at least the next year or so. Canopy Growth stock seems to take cuts as its main source of savings for now. Until it can reach a profit, investors are likely to continue seeing drops in share price for the foreseeable future. Drops so large, it may soon be kicked off the TSX.

Meanwhile, federal legalization of cannabis in the United States also doesn’t look likely. Not with an election coming up in the near future. So, if you’re hoping for a sudden climb in Canopy Growth stock, don’t hold your breath.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »